Cantor Fitzgerald, L. P. Bristol Myers Squibb CO Transaction History

Cantor Fitzgerald, L. P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $174,501 - $193,756	-2,739 Reduced 1.06%	255,884 $16.4 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $37,717 - $42,780	-574 Reduced 0.22%	258,623 $17.9 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $322,677 - $382,096	4,712 Added 1.85%	259,197 $18.6 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $12,676 - $7.49 Million	-97,508 Reduced 27.7%	254,485 $18.1 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $25.6 Million - $28.2 Million	351,993 New	351,993 $27.1 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cantor Fitzgerald, L. P., based on Form 13F filings with the SEC.

Stay updated on Cantor Fitzgerald, L. P. with notifications on news.